Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRD5A1 | P18405 | 1/20 | 0.41 |
| ▸ | HTR3A | P46098 | 1/20 | 0.40 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.40 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.40 |
| ▸ | LIG1 | P18858 | 1/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.37 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1616775 | 0.94 | KDM4E (0.42) | SRD5A1HTR3ALIG1KDM4ESMN1; SMN2 | |
| SCHEMBL15874655 | 0.94 | KDM4E (0.42) | SRD5A1HTR3ALIG1KDM4ESMN1; SMN2 | |
| SCHEMBL11840693 | 0.92 | KMT2A (0.42) | SRD5A1HTR3ALIG1KDM4ESMN1; SMN2 | |
| SCHEMBL11837854 | 0.88 | CA1 (0.41) | SRD5A1GABRA1GABRA5KDM4ESMN1; SMN2 | |
| SCHEMBL15282087 | 0.88 | SRD5A1 (0.43) | SRD5A1HTR3ALIG1HSD17B10KDM4E | |
| SCHEMBL361341 | 0.80 | LMNA (0.43) | LIG1ALOX15TSHRALDH1A1SLC6A2 | |
| SCHEMBL4917555 | 0.80 | LIG1 (0.40) | LIG1ALOX15TSHRMEN1KMT2A | |
| SCHEMBL361599 | 0.79 | DDB1 (0.48) | ALOX15TSHRKMT2AMAPT | |
| SCHEMBL23468094 | 0.77 | TRIM24 (0.36) | HSD17B10KDM4ESMN1; SMN2ALDH1A1 | |
| SCHEMBL11818914 | 0.77 | GAA (0.41) | SRD5A1HTR3ALIG1TSHRKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111662262-B | Synthesis method of 6- (4- ((2-cyclohexylthio ethyl) amino) phenyl) tetrahydro-2H-pyran-2-one | 陕西大美化工科技有限公司 | 2023-04-28 | — | — | CN | claimed |
| CN-111662262-A | Synthesis method of 6- (4- ((2-cyclohexylthio ethyl) amino) phenyl) tetrahydro-2H-pyran-2-one | 怀宁大有医药科技有限公司 | 2020-09-15 | — | — | CN | claimed |
| CN-111662262-B | Synthesis method of 6- (4- ((2-cyclohexylthio ethyl) amino) phenyl) tetrahydro-2H-pyran-2-one | 陕西大美化工科技有限公司 | 2023-04-28 | — | — | CN | disclosed |
| CN-111662262-A | Synthesis method of 6- (4- ((2-cyclohexylthio ethyl) amino) phenyl) tetrahydro-2H-pyran-2-one | 怀宁大有医药科技有限公司 | 2020-09-15 | — | — | CN | disclosed |
| EP-2668168-B1 | COMPOUNDS FOR THE REDUCTION OF ß-AMYLOID PRODUCTION | BRISTOL MYERS SQUIBB CO (US) | 2017-03-01 | — | — | EP | disclosed |
| EP-2668168-B1 | COMPOUNDS FOR THE REDUCTION OF ß-AMYLOID PRODUCTION | BRISTOL MYERS SQUIBB CO (US) | 2017-03-01 | — | — | EP | disclosed |
| US-20150336975-A1 | COMPOUNDS FOR THE REDUCTION OF BETA-AMYLOID PRODUCTION | BRISTOL-MYERS SQUIBB COMPANY (US) | 2015-11-26 | — | — | US | disclosed |
| US-20150336975-A1 | COMPOUNDS FOR THE REDUCTION OF BETA-AMYLOID PRODUCTION | BRISTOL-MYERS SQUIBB COMPANY (US) | 2015-11-26 | — | — | US | disclosed |
| US-20150336975-A1 | COMPOUNDS FOR THE REDUCTION OF BETA-AMYLOID PRODUCTION | BRISTOL-MYERS SQUIBB COMPANY (US) | 2015-11-26 | — | — | US | disclosed |
| EP-2459197-B1 | COMPOUNDS FOR THE REDUCTION OF BETA-AMYLOID PRODUCTION | BRISTOL MYERS SQUIBB CO (US) | 2015-10-14 | — | — | EP | disclosed |
| EP-2459197-B1 | COMPOUNDS FOR THE REDUCTION OF BETA-AMYLOID PRODUCTION | BRISTOL MYERS SQUIBB CO (US) | 2015-10-14 | — | — | EP | disclosed |
| US-20110212937-A1 | COMPOUNDS FOR THE REDUCTION OF BETA-AMYLOID PRODUCTION | BRISTOL-MYERS SQUIBB COMPANY | 2011-09-01 | — | — | US | disclosed |
| WO-2011014535-A1 | COMPOUNDS FOR THE REDUCTION OF β-AMYLOID PRODUCTION | BRISTOL-MYERS SQUIBB COMPANY (US) | 2011-02-03 | — | — | WO | disclosed |
| WO-2011014535-A1 | COMPOUNDS FOR THE REDUCTION OF β-AMYLOID PRODUCTION | BRISTOL-MYERS SQUIBB COMPANY (US) | 2011-02-03 | — | — | WO | disclosed |
| US-4153235-A | HYPOGLYCEMIC, HYPOTENSIVE, ANTIINFLAMMATORY, ANTICOAGULANT, DIURETIC ACTIVITIES | RICHARDSON-MERRELL INC. (US) | 1979-05-08 | — | — | US | disclosed |
| US-4126613-A | HYPOGLYCEMIC, HYPOTENSIVE, ANTIINFLAMMATORY, ANTICOAGULANT, DIURETIC | RICHARDSON-MERRELL INC. (US) | 1978-11-21 | — | — | US | disclosed |
| US-4126621-A | HYPOGLYCEMIC, HYPOTENSIVE, ANTIINFLAMMATORY, ANTICOAGULANT, DIURETIC | RICHARDSON-MERRELL INC. (US) | 1978-11-21 | — | — | US | disclosed |
| US-4126612-A | HYPOGLYCEMIC, HYPOTENSIVE, ANTIINFLAMMATORY, ANTICOAGULANT, DIURETIC | Retter, Eugene O. (US) | 1978-11-21 | — | — | US | disclosed |
| US-4126611-A | HYPOGLYCEMIC, HYPOTENSIVE, ANTIINFLAMMATORY, ANTICOAGULANT, DIURETIC | RICHARDSON-MERRELL INC. (US) | 1978-11-21 | — | — | US | disclosed |
| US-4061746-A | Lactamimide inhibitors of gastrointestinal hypersecretion | RICHARDSON-MERRELL INC. (US) | 1977-12-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110212937-A1 | COMPOUNDS FOR THE REDUCTION OF BETA-AMYLOID PRODUCTION | APP, BACE1, IAPP | SRD5A1 2535/4885HTR3A 3093/4885GABRA1 1861/4885 |
| US-20150336975-A1 | COMPOUNDS FOR THE REDUCTION OF BETA-AMYLOID PRODUCTION | APP, BACE1, IAPP | SRD5A1 2535/4885HTR3A 3093/4885GABRA1 1861/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.